Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2016-10-07 Director's Dealing
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
105年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and executives, with specific data on shares held, increases, decreases, and trust shares. The content focuses on insider shareholding disclosures rather than financial results, management changes, or other corporate events. This type of document aligns with reporting of personal share transactions or holdings by company directors and executives, which corresponds to the 'Director's Dealing' category. The document is substantive and not a brief announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the appropriate classification is 'DIRS' (Director's Dealing).
2016-10-07 Chinese
105年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and executives, showing their current holdings, pledged shares, and related percentages. It includes specific data on share pledges and insider holdings but does not contain financial statements, earnings data, or management discussion. The document is a notification of insider shareholdings and pledges, which aligns with the category of Director's Dealing (DIRS), as it reports personal share transactions or holdings by company directors and executives. The document length is relatively short (2560 characters), and it is not an announcement of a report but a direct disclosure of insider shareholdings. Therefore, the appropriate classification is DIRS with high confidence.
2016-10-07 Chinese
105年9月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative operating revenue figures for a company named 景岳, presented in a tabular format with explanations about accounting standards and reporting practices. It contains financial data for a specific month (September of 民國105年, which corresponds to 2016) and cumulative year-to-date figures, including percentage changes compared to the previous year. The document is short (767 characters) and does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it appears to be a brief financial summary or factsheet providing key revenue figures and notes on accounting standards. There is no indication that this is an announcement of a report publication or a regulatory filing. Given the concise nature and focus on key financial facts, the document best fits the category of Fund Information / Factsheet (FS).
2016-10-07 Chinese
105年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not present a full report but rather a regulatory disclosure of specific financial information. There is no indication of an annual or interim report, audit report, or earnings release. Given the nature and length, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2016-10-07 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (景岳生物科技股份有限公司) regarding the company's commitments made at the time of applying for stock listing transfer and the subsequent execution status as of the third quarter of 2016. It references compliance with a Taiwan Stock Exchange letter and details about auditor commitments and financial reporting practices. The document is short (770 characters) and serves as a disclosure or update rather than a full financial report or audit report. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-10-03 Chinese
105年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements or analysis, no mention of a fiscal period report, no management discussion, no voting results, no legal proceedings, no capital changes, and no executive changes. The document is very short (601 characters) and appears to be a regulatory disclosure of financial status related to guarantees and loans. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-09-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.